228 related articles for article (PubMed ID: 24377718)
1. Redefining Relative Biological Effectiveness in the Context of the EQDX Formalism: Implications for Alpha-Particle Emitter Therapy.
Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
Radiat Res; 2013 Dec; ():. PubMed ID: 24377718
[TBL] [Abstract][Full Text] [Related]
2. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
[TBL] [Abstract][Full Text] [Related]
3. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
4. The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses.
Joiner MC; Maughan RL; Fowler JF; Denekamp J
Radiat Res; 1983 Jul; 95(1):130-41. PubMed ID: 6878624
[TBL] [Abstract][Full Text] [Related]
5. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
6. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
[TBL] [Abstract][Full Text] [Related]
7. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
8. Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay.
Palm S; Bäck T; Claesson I; Delle U; Hultborn R; Jacobsson L; Köpf I; Lindegren S
Anticancer Res; 1998; 18(3A):1671-6. PubMed ID: 9673388
[TBL] [Abstract][Full Text] [Related]
9. Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody.
Liatsou I; Josefsson A; Yu J; Li Z; Davis K; Brayton C; Wang H; Hobbs RF; Sgouros G
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):1028-1037. PubMed ID: 37331568
[TBL] [Abstract][Full Text] [Related]
10. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
11. Generalized methods for predicting biological response to mixed radiation types and calculating equieffective doses (EQDX).
Katugampola S; Hobbs RF; Howell RW
Med Phys; 2024 Jan; 51(1):637-649. PubMed ID: 37558637
[TBL] [Abstract][Full Text] [Related]
12. The biological effectiveness of radon-progeny alpha particles. IV. Morphological transformation of Syrian hamster embryo cells at low doses.
Martin SG; Miller RC; Geard CR; Hall EJ
Radiat Res; 1995 Apr; 142(1):70-7. PubMed ID: 7899561
[TBL] [Abstract][Full Text] [Related]
13. Clinical radiobiology of proton therapy: modeling of RBE.
Jones B
Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
[TBL] [Abstract][Full Text] [Related]
14. Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
Withers HR; Mason KA; Taylor JM; Kim DK; Smathers JB
Radiat Res; 1993 Jun; 134(3):295-300. PubMed ID: 8316621
[TBL] [Abstract][Full Text] [Related]
15. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
[TBL] [Abstract][Full Text] [Related]
17. New operational quantities (RBE ×
Djeffal S; Dubeau J; Sun J; Ali F
J Radiol Prot; 2023 Sep; 43(3):. PubMed ID: 37619555
[TBL] [Abstract][Full Text] [Related]
18. The tritium RBE at low-level exposure--variation with dose, dose rate, and exposure duration.
Dobson RL; Kwan TC
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):44-62. PubMed ID: 639559
[TBL] [Abstract][Full Text] [Related]
19. Radiobiology with heavy charged particles: a historical review.
Skarsgard LD
Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
[TBL] [Abstract][Full Text] [Related]
20. Enhanced RBE of Particle Radiation Depends on Beam Size in the Micrometer Range.
Ilicic K; Dollinger G; Dombrowsky A; Greubel C; Girst S; Sammer M; Siebenwirth C; Schmid E; Friedrich T; Kundrát P; Friedland W; Scholz M; Combs SE; Schmid TE; Reindl J
Radiat Res; 2024 Feb; 201(2):140-149. PubMed ID: 38214379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
